Crown Holdings, Inc. Announces Senior Notes Offering
Crown intends to use the proceeds from the offering to repay certain existing term loan indebtedness under Crown's credit agreement.
The notes would be issued through a private placement and resold by initial purchasers to persons reasonably believed to be qualified institutional buyers under Rule 144A under the Securities Act of 1933, as amended, and to non-U.S. persons outside
Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all other information in this press release consists of forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve a number of risks, uncertainties and other factors, including regarding the contemplated size of the note offering, possible completion of the note offering, the interest rate, maturity date and other terms of any notes that may be issued, the prospective impact of the note offering, and plans to repay certain indebtedness which may cause the actual results to be materially different from those expressed or implied in the forward-looking statements. Other important factors that could cause the statements made in this press release to differ include, without limitation, that the note offering is subject to a number of conditions and approvals and the final terms may vary substantially as a result of market and other conditions. There can be no assurance that the note offering will be completed as described herein or at all. Other important factors are discussed under the caption "Forward-Looking Statements" in Crown's Form 10-K Annual Report for the year ended December 31, 2018 and in subsequent filings. Crown does not intend to review or revise any particular forward-looking statement in light of future events.
MiFID II professionals/ECPs-only/No PRIIPs KID
Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA.
For more information, contact: